EUVIMEDEUVIMED entdecken
Crossref

Refractory bullous pemphigoid during treatment with pembrolizumab in the first-line treatment of advanced non-small cell lung cancer

Renata Olech, Monika Rychlik-Grabowska, Sławomir Mańdziuk

Forum Dermatologicum · 2024

DOI: 10.5603/fd.100000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Forum Dermatologicum, 2024. Verfasst von Renata Olech und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Olech, R., Rychlik-Grabowska, M., & Mańdziuk, S. (2024). Refractory bullous pemphigoid during treatment with pembrolizumab in the first-line treatment of advanced non-small cell lung cancer. Forum Dermatologicum. https://doi.org/10.5603/fd.100000

Vancouver

Olech R, Rychlik-Grabowska M, Mańdziuk S. Refractory bullous pemphigoid during treatment with pembrolizumab in the first-line treatment of advanced non-small cell lung cancer. Forum Dermatologicum. 2024. doi:10.5603/fd.100000

BibTeX
@article{Olech2024,
  author = {Olech, Renata and Rychlik-Grabowska, Monika and Mańdziuk, Sławomir},
  title = {Refractory bullous pemphigoid during treatment with pembrolizumab in the first-line treatment of advanced non-small cell lung cancer},
  journal = {Forum Dermatologicum},
  year = {2024},
  doi = {10.5603/fd.100000}
}
Kostenlos starten →